These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34042174)

  • 1. Statin use and incident cardiovascular events in renal transplant recipients.
    Anderson JLC; van der Giet M; Gomes Neto AW; Bakker SJL; Tietge UJF
    Eur J Clin Invest; 2021 Nov; 51(11):e13594. PubMed ID: 34042174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
    Shavadia JS; Wilson J; Edmonston D; Platt A; Ephraim P; Hall R; Goldstein BA; Boulware LE; Peterson E; Pendergast J; Scialla JJ
    Am Heart J; 2021 Jan; 231():36-44. PubMed ID: 33096103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statin therapy and the incidence of atherosclerotic cardiovascular events after kidney transplantation.
    Nazoiri C; Liabeuf S; Brazier F; Nowak A; Bennis Y; Laville SM; Bodeau S; Gras-Champel V; Masmoudi K; Choukroun G; Batteux B
    Nephrol Dial Transplant; 2024 Apr; 39(5):818-829. PubMed ID: 37791395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensity of statin therapy, achieved low-density lipoprotein cholesterol levels and cardiovascular outcomes in Japanese patients after coronary revascularization. Perspectives from the CREDO-Kyoto registry cohort-2.
    Natsuaki M; Furukawa Y; Morimoto T; Nakagawa Y; Ono K; Kaburagi S; Inada T; Mitsuoka H; Taniguchi R; Nakano A; Kita T; Sakata R; Kimura T;
    Circ J; 2012; 76(6):1369-79. PubMed ID: 22447012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and cardiovascular risk in renal transplant recipients: effects of statin treatment.
    Soveri I; Abedini S; Holdaas H; Jardine A; Eriksson N; Fellström B
    Clin Transplant; 2009; 23(6):914-20. PubMed ID: 19594771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial.
    Giugliano RP; Keech A; Murphy SA; Huber K; Tokgozoglu SL; Lewis BS; Ferreira J; Pineda AL; Somaratne R; Sever PS; Pedersen TR; Sabatine MS
    JAMA Cardiol; 2017 Dec; 2(12):1385-1391. PubMed ID: 29117276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein cholesterol reduction and statin intensity in myocardial infarction patients and major adverse outcomes: a Swedish nationwide cohort study.
    Schubert J; Lindahl B; Melhus H; Renlund H; Leosdottir M; Yari A; Ueda P; James S; Reading SR; Dluzniewski PJ; Hamer AW; Jernberg T; Hagström E
    Eur Heart J; 2021 Jan; 42(3):243-252. PubMed ID: 33367526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins are associated with a reduced incidence of perioperative mortality after coronary artery bypass graft surgery.
    Pan W; Pintar T; Anton J; Lee VV; Vaughn WK; Collard CD
    Circulation; 2004 Sep; 110(11 Suppl 1):II45-9. PubMed ID: 15364837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Trends in Statin Therapy for Secondary Prevention of Atherosclerotic Cardiovascular Disease in US Adults From 2007 to 2016.
    Yao X; Shah ND; Gersh BJ; Lopez-Jimenez F; Noseworthy PA
    JAMA Netw Open; 2020 Nov; 3(11):e2025505. PubMed ID: 33216139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins in Kidney Transplant Recipients: Usage, All-Cause Mortality, and Interactions with Maintenance Immunosuppressive Agents.
    Bae S; Ahn JB; Joseph C; Whisler R; Schnitzler MA; Lentine KL; Kadosh BS; Segev DL; McAdams-DeMarco MA
    J Am Soc Nephrol; 2023 Jun; 34(6):1069-1077. PubMed ID: 36890643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for acute coronary syndrome.
    Vale N; Nordmann AJ; Schwartz GG; de Lemos J; Colivicchi F; den Hartog F; Ostadal P; Macin SM; Liem AH; Mills E; Bhatnagar N; Bucher HC; Briel M
    Cochrane Database Syst Rev; 2011 Jun; (6):CD006870. PubMed ID: 21678362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better survival with statin administration after revascularization therapy in Japanese patients with coronary artery disease: perspectives from the CREDO-Kyoto registry.
    Furukawa Y; Taniguchi R; Ehara N; Ozasa N; Haruna Y; Saito N; Doi T; Hoshino K; Shizuta S; Morimoto T; Imai Y; Teramukai S; Fukushima M; Kita T; Kimura T;
    Circ J; 2008 Dec; 72(12):1937-45. PubMed ID: 18948669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Statin Use With All-Cause and Cardiovascular Mortality in US Veterans 75 Years and Older.
    Orkaby AR; Driver JA; Ho YL; Lu B; Costa L; Honerlaw J; Galloway A; Vassy JL; Forman DE; Gaziano JM; Gagnon DR; Wilson PWF; Cho K; Djousse L
    JAMA; 2020 Jul; 324(1):68-78. PubMed ID: 32633800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HMG CoA reductase inhibitors (statins) for kidney transplant recipients.
    Navaneethan SD; Perkovic V; Johnson DW; Nigwekar SU; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2009 Apr; (2):CD005019. PubMed ID: 19370615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of statins in chronic kidney disease.
    Sheng X; Murphy MJ; Macdonald TM; Wei L
    QJM; 2012 Jul; 105(7):641-8. PubMed ID: 22383690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statin use is associated with prolonged survival of renal transplant recipients.
    Wiesbauer F; Heinze G; Mitterbauer C; Harnoncourt F; Hörl WH; Oberbauer R
    J Am Soc Nephrol; 2008 Nov; 19(11):2211-8. PubMed ID: 18650477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Achieved Low-Density Lipoprotein Levels and Major Adverse Cardiac Events in Patients With Stable Ischemic Heart Disease Taking Statin Treatment.
    Leibowitz M; Karpati T; Cohen-Stavi CJ; Feldman BS; Hoshen M; Bitterman H; Suissa S; Balicer RD
    JAMA Intern Med; 2016 Aug; 176(8):1105-13. PubMed ID: 27322095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Statin Adherence on Cardiovascular Morbidity and All-Cause Mortality in the Primary Prevention of Cardiovascular Disease: A Population-Based Cohort Study in Finland.
    Rannanheimo PK; Tiittanen P; Hartikainen J; Helin-Salmivaara A; Huupponen R; Vahtera J; Korhonen MJ
    Value Health; 2015 Sep; 18(6):896-905. PubMed ID: 26409618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of statins in elderly subjects without established cardiovascular disease: a meta-analysis.
    Savarese G; Gotto AM; Paolillo S; D'Amore C; Losco T; Musella F; Scala O; Marciano C; Ruggiero D; Marsico F; De Luca G; Trimarco B; Perrone-Filardi P
    J Am Coll Cardiol; 2013 Dec; 62(22):2090-9. PubMed ID: 23954343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.